Acquiring Company
Kohlberg Kravis Roberts
Acquired Company
Biotage
New York
SwedenEnergyFinancial ServicesReal EstateFinanceReal Estate InvestmentVenture CapitalAngel InvestmentRenewables & EnvironmentBiotechnologyLife ScienceDescription
KKR has made a US$1.22 billion tender offer for Swedish Biotage AB at SEK145 per share. The offer represents a 60.1% premium over Biotage's closing price. The acquisition requires KKR to control more than 90% of the shares and obtain necessary approvals. Biotage's board has recommended that shareholders accept the offer.
Quick answer
Kohlberg Kravis Roberts is acquiring Biotage for $1.2 billion, announced April 23, 2025. Kohlberg Kravis Roberts is based in New York, New York, United States.
- How much did Kohlberg Kravis Roberts pay for Biotage?
- The reported deal value is $1.2 billion.
- What does Kohlberg Kravis Roberts do?
- Kohlberg Kravis Roberts (KKR) is a leading global investment firm that manages multiple asset classes, including private equity, energy, infrastructure, real estate, and credit.
- Where are Kohlberg Kravis Roberts and Biotage based?
- Kohlberg Kravis Roberts is based in New York, New York, United States. Biotage is based in Sweden.
- Who are the decision-makers at Kohlberg Kravis Roberts?
- Fundz holds 5 contacts at Kohlberg Kravis Roberts. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Energy and Financial Services
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- KKR acquires OTC solutions provider OSTTRA (April 30, 2025)
- KKR to acquire OSTTRA for USD 3.1 billion (April 15, 2025)
- KKR to acquire Leixir Dental Laboratory Group (April 6, 2025)
- KKR to acquire Topcon for medical gear expansion (March 27, 2025)
- ARES MANAGEMENT LLC acquires Frontier Communications (March 21, 2025)
- KKR proposes to acquire Taiyo Holdings (May 29, 2025)
Who to call at Kohlberg Kravis Roberts, and when
When Kohlberg Kravis Roberts changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Kohlberg Kravis Roberts raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Kohlberg Kravis Roberts, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Kohlberg Kravis Roberts. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Kohlberg Kravis Roberts makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Biotage?
Biotage was acquired by Kohlberg Kravis Roberts, based in New York. The deal was reported on April 23, 2025. Kohlberg Kravis Roberts (KKR) is a leading global investment firm that manages multiple asset classes, including private equity, energy, infrastructure, real estate, and credit. Kohlberg Kravis Roberts is publicly traded (KKR) and operates in Energy.
When did Kohlberg Kravis Roberts acquire Biotage?
Kohlberg Kravis Roberts's acquisition of Biotage was reported on April 23, 2025. KKR has made a US$1.22 billion tender offer for Swedish Biotage AB at SEK145 per share. The offer represents a 60.1% premium over Biotage's closing price. The acquisition requires KKR to control more than 90% of the shares and obtain necessary approvals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Biotage do?
Biotage is a global leader in analytical and preparative chromatography, offering innovative solutions for the pharmaceutical, biotechnology, and environmental industries. It is privately held, operating in Biotechnology, and is based in Sweden.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.